Library
Pharmacological vs. classical approaches in the design of first in man clinical drug trials.
1 December 2017. doid: 10.1111/bcp.13422
van den Bogert CA, Cohen AF, Leufkens HGM, van Gerven JMA
View publicationThe aims of the present study were to investigate the role of pharmacology in the design of first-in-man (FIM) trials in the Netherlands, and to evaluate the change in design approaches between 2007 and 2015.
Advancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
